New hope for OCD? brain medication trial underway
NCT ID NCT05624528
Summary
This study is testing whether a medication called tolcapone can help reduce symptoms of obsessive-compulsive disorder (OCD). Researchers are comparing tolcapone against a placebo in 49 adults with moderate to severe OCD over 8 weeks. The study also examines how the medication affects thinking skills and whether genetics influence treatment response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.